Metoclopramide to Aid Establishment of Breastfeeding:a Randomised Controlled Trial

• Status: Completed
• Trial end date: 2009-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

Hypothesis: Early use of oral metoclopramide can hasten and improve the establishment of lactogenesis II in mothers after preterm and term deliveries.

The study hopes to show that metoclopramide can be effective to establish and sustain Lactogenesis II for both preterm and term infants.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National University Hospital, Singapore
• Treatments: Metoclopramide

Criteria

Inclusion Criteria:

All pregnant women who intend to breastfeed, from 28 weeks to term, who have not met the exclusion criteria

Exclusion Criteria:

1. Patients who have epilepsy or on anti-seizure medications,

2. Patients who have a history of significant depression or are on antidepressant drugs

3. Patients who have pheochromocytoma or uncontrolled hypertension

4. Patients who have intestinal bleeding or obstruction

5. Patients who have a known allergy or prior reaction to metoclopramide, or any other contraindications to the use of metoclopramide

6. Patients who have diabetes and hyperprolactinaemia

7. Patients with HIV infection

8. Current pregnancy complicated by fetal congenital anomalies and multiple fetuses